Select Medical (NYSE:SEM) Upgraded to “Buy” at StockNews.com

Select Medical (NYSE:SEM) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday.

SEM has been the subject of a number of other research reports. Benchmark reiterated a “buy” rating and set a $48.00 price target on shares of Select Medical in a research note on Friday, November 1st. Royal Bank of Canada lifted their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Bank of America assumed coverage on Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price target for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $40.75.

Select Medical Trading Down 2.5 %

Shares of Select Medical stock opened at $39.18 on Wednesday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical has a 52 week low of $21.56 and a 52 week high of $40.98. The stock has a 50 day moving average price of $34.56 and a two-hundred day moving average price of $34.53. The stock has a market capitalization of $5.07 billion, a PE ratio of 18.31, a price-to-earnings-growth ratio of 2.04 and a beta of 1.42.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. Select Medical’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.46 EPS. As a group, equities analysts anticipate that Select Medical will post 2.16 earnings per share for the current fiscal year.

Institutional Trading of Select Medical

A number of hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC increased its position in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after purchasing an additional 330 shares during the last quarter. Foster & Motley Inc. raised its position in Select Medical by 3.1% in the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock worth $426,000 after acquiring an additional 370 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Select Medical by 6.6% in the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock valued at $198,000 after acquiring an additional 405 shares during the last quarter. KBC Group NV grew its position in shares of Select Medical by 4.5% during the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after acquiring an additional 563 shares during the period. Finally, Arizona State Retirement System increased its stake in shares of Select Medical by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 593 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.